Marshall Wace, LLP Intra Cellular Therapies, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,160,973 shares of ITCI stock, worth $97.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,160,973

Previous 499,015 132.65%

Holding current value

$97.2 Million

Previous $34.2 Million 148.38%

% of portfolio

0.11%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.99 - $80.84 $45 Million - $53.5 Million	661,958 Added 132.65%	1,160,973 $84.9 Million
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $32.3 Million - $39.8 Million	499,015 New	499,015 $34.2 Million
Q4 2023 Feb 14, 2024	SELL	$46.37 - $73.65 $867,072 - $1.38 Million	-18,699 Reduced 43.54%	24,249 $1.74 Million
Q3 2023 Nov 14, 2023	SELL	$52.09 - $64.1 $3.41 Million - $4.2 Million	-65,500 Reduced 60.4%	42,948 $2.24 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $5.93 Million - $7.21 Million	108,448 New	108,448 $6.87 Million
Q2 2022 Aug 15, 2022	SELL	$43.0 - $65.64 $108 Million - $165 Million	-2,519,764 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $5.09 Million - $8.16 Million	131,470 Added 5.5%	2,519,764 $154 Million
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $3.26 Million - $4.95 Million	92,660 Added 4.04%	2,388,294 $125 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $13.7 Million - $20.2 Million	-475,670 Reduced 17.16%	2,295,634 $85.6 Million
Q2 2021 Aug 13, 2021	SELL	$29.3 - $44.5 $1.85 Million - $2.81 Million	-63,156 Reduced 2.23%	2,771,304 $113 Million
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $5.58 Million - $7.16 Million	-181,272 Reduced 6.01%	2,834,460 $96.2 Million
Q4 2020 Feb 16, 2021	BUY	$23.34 - $32.22 $78,305 - $108,098	3,355 Added 0.11%	3,015,732 $95.9 Million
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $29.8 Million - $54 Million	1,694,447 Added 128.57%	3,012,377 $77.3 Million
Q2 2020 Aug 13, 2020	BUY	$14.35 - $26.64 $9.09 Million - $16.9 Million	633,152 Added 92.46%	1,317,930 $33.8 Million
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $8.43 Million - $22.7 Million	684,778 New	684,778 $10.5 Million

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.1M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Intra Cellular Therapies, Inc. Transaction History